Built on Experience
For 25+ years, Medidata has redefined clinical development to accelerate smarter treatments and healthier lives—and continues to shape what comes next.
Powering Smarter Treatments and Healthier People
Medidata, a Dassault Systèmes’ brand and global leader in clinical trial solutions, has driven ground-breaking technological innovation across 38,000+ trials and 12 million patients, delivering industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry.
Today, one million users across 2,300 organizations trust our seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster.
Leadership
Our Story
Medidata was founded to drive smarter treatments and healthier lives. What followed is a 25+ year journey of milestones that reshaped clinical development—and continue to define what’s next.
Medidata Is Founded
Fund manager Tarek Sherif moves into a small office with tech entrepreneur and researcher Glen de Vries, who hand-codes Medidata’s original software. Together with Ed Ikeguchi, they found Medidata.
June 1999
EDC Launches
The first software to digitally collect clinical trial data. Later named Rave (Electronic Data Capture), it transforms data capture to become the world’s most advanced, robust, and secure system for managing clinical trial site, patient, and lab data.
June 1999
Medidata Opens London Office
June 2004
Medidata Opens Tokyo Office
June 2005
Medidata NEXT Launches
A Rave best-practices forum, the Medidata User Group (MUG), becomes Medidata Symposium in 2015 and Medidata NEXT in 2017. Today, it convenes industry leaders and patient advocates to shape the future of life sciences.
2006
Initial Public Offering on NASDAQ
June 2009
Acquisition of Clinical Force
Adds Medidata CTMS® (Clinical Trial Management System) to solutions.
June 2011
Acquisition of Mytrus
Adds eConsent to the Medidata Platform.
April 2017
Acquisition of CHITA
Adds regulated content management and eTMF capabilities to the Medidata Platform.
June 2017
Acquisition of SHYFT Analytics
Powers customers’ digital transformation with AI and real-world analytics.
June 2018
Launches Medidata AI
Combines data, technology, and deep expertise to deliver actionable insights across the clinical development continuum—optimizing study execution and commercial success, and proving therapy value.
June 2019
Dassault Systèmes Acquires Medidata
Dassault Systèmes, the 3DEXPERIENCE company, acquires Medidata to accelerate the digital transformation of life sciences —pushing the boundaries of innovation and learning to build a more sustainable future for patients and society.
Read MoreOctober 2019
Responding to COVID-19 with Data and Direction
Throughout 2020, Medidata publishes nine white papers analyzing COVID-19’s impact on drug and vaccine trials—assessing patient disruption and delivering data-driven guidance to help sponsors and CROs sustain and adapt studies worldwide.
March 2020
Launches myMedidata
Built for and with patients, myMedidata is an award-winning portal enabling participants to learn, enroll, and engage in trials from any device—powering scalable, flexible, decentralized, and hybrid study models.
April 2020
Powers Moderna’s COVID-19 Vaccine Trials
Medidata’s cloud platform enables the rapid advancement of Moderna’s mRNA-1273 program, supporting its 30,000-participant Phase 3 study with the scale, speed, and resilience required during the global pandemic.
Press ReleaseJuly 2020
Medidata Synthetic Control Arm® Supported by the FDA
In a regulatory first, the FDA permits Medicenna to use a hybrid external control arm in a Phase 3 registrational trial—building on a Phase 2 study in recurrent glioblastoma strengthened by Medidata’s Synthetic Control Arm®.
Press ReleaseOctober 2020
Launches myMedidata Registries
Expanding our patient portal to engage participants before enrollment and long after trial completion supports long-term follow-up and safety surveillance.
Press ReleaseJune 2021
Introduces the First Unified Platform for DCTs
The industry’s first end-to-end, secure platform for decentralized clinical trials enables sponsors and CROs to manage drug, vaccine, and device studies seamlessly across the development continuum.
Press ReleaseJune 2021
Launches Sensor Cloud and the Sensor Cloud Network
Delivering advanced data models and proprietary algorithms that rapidly ingest, normalize, and analyze patient-generated data accelerates decisions and timelines. The Sensor Cloud Network unites CROs, device makers, sponsors, analytics firms, and academia in the industry’s first cross-sector collaboration.
Read MoreOctober 2021
Rave Imaging Surpasses 1,000 Studies
Exceeding 1,000 supported trials, Rave Imaging processes more than 100 million images annually—scaling secure, cloud-based imaging management for global clinical research.
October 2021
Remembering Glen de Vries
Glen set the highest standard for Medidata and championed our commitment to always innovate to solve our industry’s most complex problems. We will further Glen’s mission by continuing to push the boundaries of what’s possible.
November 2021
Opens up Patient Insights Program
Enabling sponsors, CROs, and sites to embed patient perspectives directly into software design and improve the clinical research experience.
Read MoreFebruary 2022
30,000 Trials, 9 Million Participants
The first life sciences technology company to surpass 30,000 trials and 9 million study volunteers.
Press ReleaseMarch 2023
Showcases Clinical Data Studio and Health Record Connect
New experiences for enhancing and streamlining clinical data workflows.
November 2023
Anthony Costello Named CEO
Anthony Costello has advanced the use of technology in clinical trials for nearly 30 years. Across numerous leadership roles from entrepreneur to corporate c-suite, Anthony has transformed the patient, site, and sponsor experience, while accelerating the delivery of life-changing treatments.
March 2024
Recognized for Site Innovation
Medidata was presented with the inaugural Site Innovation Award for its groundbreaking work in improving efficiency in clinical trials by the Summit for Clinical Ops Executives (SCOPE).
Press ReleaseMarch 2024
Global Rollout of Clinical Data Studio
Delivers a unified research experience with greater data quality control.
Clinical Data StudioMarch 2024
Launches Patient Payments
A new solution for streamlining trial-related stipends and reimbursements for patients participating in clinical research.
Patient PaymentsSeptember 2024
Introduces Rave Lite
An extension of its gold-standard clinical research software, Rave, and designed explicitly for Phase I and IV studies.
Rave LiteOctober 2024
Enters CNS Space with Cogstate Partnership
A partnership with neuroscience solutions leader Cogstate reshapes clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders.
Press ReleaseOctober 2024
35,000 Trials,10 Million Participants
Surpasses 35,000 trials and 10 million study volunteers worldwide.
November 2024
Integrates UK Health Costing Data
First to integrate UK-mandated Health Costing Data into its financial management portfolio.
February 2025
Another Milestone
Surpasses 36,000 Clinical Trials and 11 Million Participants
March 2025
Launches Site Insights Program
Elevating the Site Voice and strengthening site partnership and performance in clinical trials.
MARCH 2025
Launches Protocol Optimization
Unveils Protocol Optimization at ASCO, advancing data-driven study design and execution.
May2025
Remembering Glen de Vries
Entrepreneur, philanthropist, aviation and space enthusiast, died on November 11, 2021.
We’re proud to honor the legacy of our dear friend and co-founder, Glen de Vries. His curiosity, creativity, and compassion continue to inspire us as we all push forward on his quest to bring help and hope to patients around the globe.
Glen set the highest standard for Medidata and championed our commitment to always innovating to solve our industry’s most complex problems. We will further Glen’s mission by continuing to push the boundaries of what’s possible.
Trust and Transparency
Your innovations must be as trustworthy as they are transformative. That’s why every AI capability is built on secure data practices, explainable models, and accountable governance.
Ethical, human-centered intelligence helps you move faster—
while protecting patients, data, and regulatory integrity.
Values and Corporate Social Responsibility
Our industry-leading CSR program helps you partner with a company built for long-term, responsible growth.
Aligned with our parent company’s goal of carbon neutrality by 2040, we invest in sustainable innovation, build strategic partnerships, and continuously strengthen employee expertise—so your trials advance with resilience, accountability, and measurable impact.
IMPACT
Social Innovation Lab
SIL is a skills-based volunteering program that pairs employees with non-profit partners—working on priority projects that NPOs don’t have the resources to drive.
Supporting STEM Innovation
Medidata can provide funds for STEM education, mentor students, and offer insight into the exciting world of life sciences. Our partners include Girls Who Code, All Star Code, and Career Spring.
Gift Matching
Causes that matter to our employees matter to us. We matched approximately $350,000 of employee donations to causes they are passionate about in their communities.
Sustainability
We measure our progress toward carbon neutrality by 2040 by reporting under Dassault Systèmes as a subsidiary for global environmental, social, and governance (ESG) management.
Awards and Recognition
2024
IDC MarketScape Worldwide Life Science R&D DCT Technology Solutions and Consulting Services
2025
Medidata x Cogstate Partnership
Best Clinical Trial Technology Solution Provider
2023 & 2024
Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms
2022 & 2023
Everest Group Decentralized Clinical Trial Platforms
Our CSR Programs Have Supported
PROJECT PARTNERS
